PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 4 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

27 June 2026

  1. (diff | hist) 14:35 Talk:Sterility testing 885 +87 NPOV_Nadia (talk | contribs) /* Treat as non-sterile */ reply
  2. (diff | hist) 13:22 Talk:Sharps disposal 674 +407 BalanceBirdie (talk | contribs) /* Colour-coding table is England-specific and presented as general */ new section
  3. (diff | hist) 12:13 Sharps disposal 18,558 ±0 EscalationEira (talk | contribs) expand §Container requirements [rollback]
  4. (diff | hist) 11:10 Talk:Sterility testing 674 +167 DisclosureDido (talk | contribs) /* Treat as non-sterile */ new section
  5. (diff | hist) 10:05 Hubei Jianxiang Bioscience 14,855 ±0 NPOV_Nadia (talk | contribs) add the minimum order quantity for custom synthesis [rollback]
  6. (diff | hist) 09:04 Peptide harm reduction 4,800 ±0 DisparityDagny (talk | contribs) consistent en dashes in ranges [rollback]

26 June 2026

  1. (diff | hist) 20:23 Counterfeit peptide 5,488 ±0 PrimarySrcPatia (talk | contribs) add the turnaround time the service publishes [rollback]
  2. (diff | hist) 14:30 Talk:Trifluoroacetate counterion 885 +171 MolarMassMaeve (talk | contribs) /* Range of counterion content */ reply
  3. (diff | hist) 13:50 Talk:Global access disparity 748 +90 DisparityDagny (talk | contribs) /* Capacity constraint has eased */ reply
  4. (diff | hist) 11:05 Talk:Trifluoroacetate counterion 674 +110 SigFigSindri (talk | contribs) /* Range of counterion content */ new section
  5. (diff | hist) 10:15 Talk:Global access disparity 537 +121 SupplyWatchSuri (talk | contribs) /* Capacity constraint has eased */ new section
  6. (diff | hist) 09:15 Talk:CagriSema 822 +72 CagriCass (talk | contribs) /* The under-titration question */ reply

25 June 2026

  1. (diff | hist) 13:40 Talk:CagriSema 611 +127 EndpointEnid (talk | contribs) /* The under-titration question */ reply
  2. (diff | hist) 12:27 Peptide supply chain 8,410 ±0 DPP4_Dagmar (talk | contribs) expand §Handovers, and why they are where things go missing [rollback]
  3. (diff | hist) 10:05 Talk:CagriSema 400 +224 CagriCass (talk | contribs) /* The under-titration question */ new section
  4. (diff | hist) m b 09:41 Zhuhai Kerui Biotechnology 14,711 ±0 ArchiveBot (talk | contribs) bot: update parent category chain [rollback]
  5. (diff | hist) 05:45 Bachem Holding (Suzhou) 15,124 ±0 PrimarySrcPatia (talk | contribs) convert the product range to a table so the documentation column lines up [rollback]

24 June 2026

  1. (diff | hist) 18:01 Shanghai Wibson Biotechnology 15,440 ±0 ReportReaderRilla (talk | contribs) add the lead time for catalogue lines, as reported [rollback]
  2. (diff | hist) 14:50 Talk:Counterfeit peptide 885 +153 LyophilLena (talk | contribs) /* Cake appearance as evidence */ reply
  3. (diff | hist) 13:55 Talk:List of GLP-1 receptor agonists 748 +86 ListMakerLumi (talk | contribs) /* Inclusion is not endorsement */ reply
  4. (diff | hist) m b 11:46 Customs seizure 4,785 ±0 ArchiveBot (talk | contribs) bot: update parent category chain [rollback]
  5. (diff | hist) m 11:40 Global access disparity 4,391 ±0 TierTwoTansy (talk | contribs) add the compounded-alternative point with its regulatory caveat [rollback]
  6. (diff | hist) 11:15 Talk:Counterfeit peptide 674 +163 BlankVialBo (talk | contribs) /* Cake appearance as evidence */ new section
  7. (diff | hist) m 10:31 Sharps disposal 18,558 +657 DrTitration (talk | contribs) give the concentration in mg/mL as well as in units [rollback]
  8. (diff | hist) 10:20 Talk:List of GLP-1 receptor agonists 537 +153 NPOV_Nadia (talk | contribs) /* Inclusion is not endorsement */ new section
  9. (diff | hist) 08:17 Purity claim inflation 5,660 ±0 AnalyticalAnnie (talk | contribs) de-duplicate a repeated sentence [rollback]
  10. (diff | hist) m 06:50 Trial data comparison 7,303 ±0 PharmDrafts (talk | contribs) add the note that vial overfill is not assumed [rollback]
  11. (diff | hist) 06:00 Lyophilisation 28,679 ±0 MicrodoseMagnus (talk | contribs) alphabetise the see-also list [rollback]
  12. (diff | hist) 03:45 Shenzhen Hybio Pharmaceutical 17,716 ±0 EndotoxinEd (talk | contribs) label the reception tally as weak, self-selected evidence at this point of use [rollback]
  13. (diff | hist) 00:38 Peptide aggregation 5,516 ±0 DiluentDiya (talk | contribs) add the counterion determination method by name [rollback]

23 June 2026

  1. (diff | hist) 17:54 Shanghai Sigma-Audley New Material Technology 15,579 ±0 TrialsTabitha (talk | contribs) attribute the capability claim to the organisation's own material [rollback]
  2. (diff | hist) 14:45 Talk:Customs seizure 885 +103 FreightFenna (talk | contribs) /* Broken cold chain on detention */ reply
  3. (diff | hist) 11:10 Talk:Customs seizure 674 +112 ColdChainCleo (talk | contribs) /* Broken cold chain on detention */ new section

22 June 2026

  1. (diff | hist) 14:50 Talk:Medutest 885 +221 Areapercent_Ayo (talk | contribs) /* Purity versus content example */ reply
  2. (diff | hist) 13:55 Talk:Cost per milligram 748 +60 BalanceBirdie (talk | contribs) /* Documentation is not in the price */ reply
  3. (diff | hist) 13:07 GLP-1 receptor agonist 11,264 ±0 TimelineTiernan (talk | contribs) rm the equipotency claim — the cited paper does not make it [rollback]
  4. (diff | hist) 11:05 Talk:Medutest 674 +134 PlainNumbersPip (talk | contribs) /* Purity versus content example */ new section
  5. (diff | hist) 10:20 Talk:Cost per milligram 537 +163 COA_Colwyn (talk | contribs) /* Documentation is not in the price */ new section
  6. (diff | hist) m 08:36 Underfilling 4,882 ±0 UnderfillUna (talk | contribs) add the laboratory accreditation status, or say plainly that it is not stated [rollback]
  7. (diff | hist) m 07:26 Syringe dead space 20,968 ±0 SyringeSybille (talk | contribs) add the note that a smaller diluent volume raises concentration, not dose [rollback]
  8. (diff | hist) 06:47 Sharps disposal 17,901 ±0 HarmReductionHen (talk | contribs) move a stray full stop inside the reference [rollback]

21 June 2026

  1. (diff | hist) 21:52 Grey market 4,279 ±0 CounterfeitCato (talk | contribs) expand §What the term does not mean [rollback]
  2. (diff | hist) m 17:27 Certificate of analysis 10,014 ±0 PrepHPLC_Pia (talk | contribs) expand §The fields most often missing [rollback]
  3. (diff | hist) 16:12 Solid-phase peptide synthesis 5,359 ±0 eGFR_Esme (talk | contribs) unpipe a link that did not need piping [rollback]
  4. (diff | hist) 14:45 Talk:Preparative HPLC purification 885 +132 CrossRefCleve (talk | contribs) /* Pooling decisions */ reply
  5. (diff | hist) 13:50 Talk:Liquid chromatography-mass spectrometry 748 +107 Chromatokid (talk | contribs) /* Resolution determines what could be seen */ reply
  6. (diff | hist) 13:08 Chain of custody 5,157 ±0 StopperingSteff (talk | contribs) add the turnaround time the service publishes [rollback]
  7. (diff | hist) 11:20 Talk:Preparative HPLC purification 674 +142 LotTraceLuka (talk | contribs) /* Pooling decisions */ new section
  8. (diff | hist) 10:33 Multi-dose vial 24,688 ±0 DeadSpaceDot (talk | contribs) rm a duplicated category [rollback]
  9. (diff | hist) 10:15 Talk:Liquid chromatography-mass spectrometry 537 +118 SigFigSindri (talk | contribs) /* Resolution determines what could be seen */ new section
  10. (diff | hist) 10:03 Glucagon-like peptide-1 12,294 ±0 Chromatokid (talk | contribs) rm a duplicated category [rollback]
  11. (diff | hist) m 09:21 Exenatide 5,754 ±0 DataTableDunja (talk | contribs) give the INN alongside the trade name at first mention [rollback]
  12. (diff | hist) 08:50 Adverse effects of GLP-1 receptor agonists 5,791 ±0 AppendixAlva (talk | contribs) add the discontinuation rate attributable to this effect [rollback]
  13. (diff | hist) 06:59 Flourishglobal Peptide Biotech 14,771 ±0 RfC_Rasmus (talk | contribs) convert a hard-coded date to the house format [rollback]
  14. (diff | hist) 04:28 Chinese Peptide Company 15,513 ±0 VerifyFirstVida (talk | contribs) expand §External links [rollback]
  15. (diff | hist) m 02:34 Prior authorisation 4,216 ±0 ShortDescShai (talk | contribs) British spelling per PP:MOS [rollback]
  16. (diff | hist) m 00:50 Vial 26,012 ±0 LipidLedgerLou (talk | contribs) add the shelf temperature and the primary drying step to the cycle description [rollback]

20 June 2026

  1. (diff | hist) m b 22:45 Repackaging 4,759 ±0 CategoryBot (talk | contribs) bot: normalise unit spacing [rollback]
  2. (diff | hist) 22:25 Research use only 7,990 ±0 API_Aurora (talk | contribs) rm the advice on importation; the article describes the position and does not advise [rollback]
  3. (diff | hist) 20:42 Contract development and manufacturing organisation 5,011 ±0 OrphanPageOrin (talk | contribs) de-orphan [rollback]
  4. (diff | hist) 17:00 Retatrutide 7,421 ±0 TirzTaxonomist (talk | contribs) add category for the drug class [rollback]
  5. (diff | hist) m b 16:43 Insulin syringe 4,944 ±0 CiteBot (talk | contribs) bot: repair redlinked category [rollback]
  6. (diff | hist) 13:55 Talk:Lixisenatide 748 +121 MolarMassMaeve (talk | contribs) /* Non-attenuating emptying delay */ reply
  7. (diff | hist) 13:33 Sarcopenia 4,491 ±0 AnalyticalAnnie (talk | contribs) add the note that a single value out of range is not a finding [rollback]
  8. (diff | hist) 13:31 Fmoc chemistry 4,618 ±0 DPP4_Dagmar (talk | contribs) correct the freezer temperature range given for long-term storage [rollback]
  9. (diff | hist) 13:20 Talk:Amylin receptor agonist 885 +186 COA_Colwyn (talk | contribs) /* Method-coverage sentence */ reply
  10. (diff | hist) 11:23 Dual incretin agonist 5,851 ±0 BlindSampleBrid (talk | contribs) expand §Beyond GIP and GLP-1 [rollback]
  11. (diff | hist) 10:20 Talk:Lixisenatide 537 +113 EmptyingElke (talk | contribs) /* Non-attenuating emptying delay */ new section
  12. (diff | hist) 09:50 Talk:Amylin receptor agonist 674 +222 DisclosureDido (talk | contribs) /* Method-coverage sentence */ new section
  13. (diff | hist) m 09:12 ChinaPeptides 14,979 ±0 AppendixAlva (talk | contribs) label the reception tally as weak, self-selected evidence at this point of use [rollback]
  14. (diff | hist) 05:53 WuXi TIDES 16,434 ±0 COA_Colwyn (talk | contribs) state the city and province of the registered address [rollback]
  15. (diff | hist) 01:33 Mass spectrometry 5,612 ±0 GradientGus (talk | contribs) correct the water-content figure — the source reports it on a dry basis [rollback]
  16. (diff | hist) m b 01:21 USP General Chapter 71 4,657 ±0 StubSorterBot (talk | contribs) bot: normalise citation format [rollback]

19 June 2026

  1. (diff | hist) 23:14 HOMA-IR 4,511 ±0 PanelPlannerPam (talk | contribs) add the paediatric interval with the caveat that it differs [rollback]
  2. (diff | hist) m b 19:50 Hunan Aslsen Technology 15,492 ±0 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  3. (diff | hist) m 19:26 Insulin syringe unit conversion 6,290 ±0 Chromatokid (talk | contribs) state the diluent volume the default assumes [rollback]
  4. (diff | hist) m b 19:00 Cold chain 27,220 ±0 CiteBot (talk | contribs) bot: normalise unit spacing [rollback]
  5. (diff | hist) 17:56 Drug master file 4,325 ±0 Peptide_Pete (talk | contribs) add the telehealth prescribing point as attributed [rollback]
  6. (diff | hist) 15:49 Body composition assessment 5,029 ±0 GMP_Gita (talk | contribs) ce per PP:MOS [rollback]
  7. (diff | hist) 14:33 Talk:Trial data comparison 1,244 +242 EndpointEnid (talk | contribs) /* Cross-trial tabulation and the estimand problem */ reply
  8. (diff | hist) 13:55 Talk:Analytical method validation 885 +105 HedgeHedda (talk | contribs) /* Uncharacterised is not wrong */ reply
  9. (diff | hist) 13:55 Talk:Patent expiry and biosimilars 748 +85 ImportPolicyIggy (talk | contribs) /* Expiry does not change research supply */ reply
  10. (diff | hist) m b 13:07 Blind sampling 8,193 ±0 StubSorterBot (talk | contribs) bot: flag bare reference [rollback]
  11. (diff | hist) 11:46 Cost per milligram 4,125 ±0 BacWaterBarnaby (talk | contribs) add the year-on-year change with both endpoints stated [rollback]
  12. (diff | hist) 10:20 Talk:Analytical method validation 674 +172 BalanceBirdie (talk | contribs) /* Uncharacterised is not wrong */ new section
  13. (diff | hist) 10:20 Talk:Patent expiry and biosimilars 537 +147 GreyMarketGreer (talk | contribs) /* Expiry does not change research supply */ new section
  14. (diff | hist) 08:32 Sharps disposal 17,901 +1,544 StabilityStig (talk | contribs) expand §Upstream prevention [rollback]
  15. (diff | hist) 07:39 SinoPep 18,360 ±0 GroupBuyGalen (talk | contribs) add the incorporation year, attributed to the registry record [rollback]
  16. (diff | hist) 07:04 Baseline laboratory panel 4,429 ±0 ApoB_Aurelio (talk | contribs) fix a broken wikilink [rollback]
  17. (diff | hist) m 07:02 MOTS-c 4,670 ±0 EpitalonEoin (talk | contribs) expand §Reported effects [rollback]
  18. (diff | hist) 06:29 Beyond-use date 23,171 ±0 Chromatokid (talk | contribs) state the assumption that the whole vial is reconstituted at once [rollback]
  19. (diff | hist) 03:27 PeptideMeter 4,925 ±0 PurityClaimPia (talk | contribs) add the second-opinion point: two services, one lot, is a stronger record [rollback]
  20. (diff | hist) m b 03:01 Orforglipron 5,647 ±0 CategoryBot (talk | contribs) bot: add drug-class category [rollback]
  21. (diff | hist) m 01:45 Reconstitution of lyophilised peptides 5,761 ±0 Chromatokid (talk | contribs) the rounding in the table lost a decimal place that matters at low doses [rollback]
  22. (diff | hist) 01:10 Amylin receptor agonist 5,245 ±0 AmylinAmos (talk | contribs) state the substitution in one-letter code as well, per PP:MOS [rollback]

18 June 2026

  1. (diff | hist) 23:09 AmbioPharm 17,173 ±0 PrepHPLC_Pia (talk | contribs) alphabetise the see-also list [rollback]
  2. (diff | hist) 22:40 Subcutaneous injection 5,293 ±0 Chromatokid (talk | contribs) fix hyphenation per PP:MOS [rollback]
  3. (diff | hist) 20:27 Peptide stability table 6,886 ±0 DeletionDeb (talk | contribs) add the citation for the stability figures taken from the labelling [rollback]
  4. (diff | hist) 15:25 Talk:Lot traceability 885 +124 LotTraceLuka (talk | contribs) /* Consolidated shipments */ reply
  5. (diff | hist) m b 15:17 GL Biochem (Shanghai) 16,491 ±0 CategoryBot (talk | contribs) bot: update parent category chain [rollback]